Summary
Experiments on streptozotocin-diabetic rats have indicated that axonal transport of choline acetyltransferase is reduced in sciatic nerve. Treatment with an aldose reductase inhibitor both prevented and reversed this defect which was related to marked accumulations of sorbitol and fructose. Concurrent with these accumulations the content of myo-inositol in diabetic peripheral nerve is depleted. Further experiments taking account of nerve water content showed that the depletion of myo-inositol was ‘real’ not apparent. When the level of myo-inositol was maintained, either by feeding myo-inositol or by the inhibition of aldose reductase, the development of defective axonal transport of choline acetyltransferase and choline-containing lipids was prevented.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clements Jr RS. Diabetic neuropathy: new concepts of its etiology. Diabetes 28: 604–611, 1979
Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA. Polyol pathway activity and myo-inositol metabolism, a suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes 32: 988–992, 1983
Gabbay KH. The sorbitol pathway and the complications of diabetes. New England Journal of Medicine 288: 831–836, 1973
Gabbay KH, Merola LO, Field RA. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151: 209–210, 1966
Gillon KRW, Hawthorne JN. Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats. Biochemical Journal 210: 775–781, 1983
Gillon KRW, Hawthorne JN, Tomlinson DR. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia 25: 365–371, 1983
Greene DA, de Jesus PV, Winegrad AI. Effects of insulin and dietary myo-inositol on impaired peripheral motor conduction velocity in acute streptozotocin diabetics. Journal of Clinical Investigation 55: 1326–1336, 1975
Jakobsen J. Peripheral nerves in early experimental diabetes. Expansion of the endoneurial space as a cause of increased water content. Diabetologia 14: 113–119, 1978
Mayer JH, Tomlinson DR. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433–438, 1983
Robinson JP, Tomlinson DR. Impaired axonal transport of choline-containing lipids in rats with experimental diabetes mellitus and its prevention by sorbinil, an aldose reductase inhibitor. Journal of Physiology 369: 158P, 1985
Tomlinson DR, Mayer JH. Defects of axonal transport in diabetes mellitus — a possible contribution to the aetiology of diabetic neuropathy. Journal of Autonomic Pharmacology 4: 59–72, 1984
Tomlinson DR, Mayer JH. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol. Experimental Neurology 89: 420–427, 1985
Tomlinson DR, Moriarty RJ, Mayer JH. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil. Diabetes 33: 470–476, 1984
Tomlinson DR, Townsend J, Fretten P. Prevention of defective axonal transport in streptozotocin-diabetic rats by treatment with ‘Statil’ (ICI 128436), an aldose reductase inhibitor. Diabetes 34: 970–972, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tomlinson, D.R., Willars, G.B. & Robinson, J.P. Prevention of Defects of Axonal Transport in Experimental Diabetes by Aldose Reductase Inhibitors. Drugs 32 (Suppl 2), 15–18 (1986). https://doi.org/10.2165/00003495-198600322-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600322-00005